These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22324986)

  • 1. New developments in invasive fungal disease.
    Groll AH; Lumb J
    Future Microbiol; 2012 Feb; 7(2):179-84. PubMed ID: 22324986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging moulds: epidemiological trends and antifungal resistance.
    Miceli MH; Lee SA
    Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
    Metcalf SC; Dockrell DH
    J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
    Silva V; Zepeda G; Alvareda D
    Rev Iberoam Micol; 2003 Mar; 20(1):21-3. PubMed ID: 12825977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meeting the challenge of invasive fungal infections: part 1.
    Maertens J; Lyon S
    Future Microbiol; 2013 Sep; 8(9):1063-5. PubMed ID: 24020734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging systemic fungal infections.
    Galimberti R; Torre AC; Baztán MC; Rodriguez-Chiappetta F
    Clin Dermatol; 2012; 30(6):633-50. PubMed ID: 23068151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of amphotericin B in the treatment of invasive fungal infections.
    Klepser M
    J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging opportunistic yeast infections.
    Miceli MH; Díaz JA; Lee SA
    Lancet Infect Dis; 2011 Feb; 11(2):142-51. PubMed ID: 21272794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging fungal resistance.
    Baddley JW; Moser SA
    Clin Lab Med; 2004 Sep; 24(3):721-35, vii. PubMed ID: 15325062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope
    Stemler J; Salmanton-García J; Seidel D; Alexander BD; Bertz H; Hoenigl M; Herbrecht R; Meintker L; Meißner A; Mellinghoff SC; Sal E; Zarrouk M; Koehler P; Cornely OA
    Mycoses; 2020 Mar; 63(3):265-274. PubMed ID: 31769549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact.
    Kanafani ZA; Perfect JR
    Clin Infect Dis; 2008 Jan; 46(1):120-8. PubMed ID: 18171227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging and less common fungal pathogens.
    Fleming RV; Walsh TJ; Anaissie EJ
    Infect Dis Clin North Am; 2002 Dec; 16(4):915-33, vi-vii. PubMed ID: 12512187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal treatment in pediatric patients.
    Zaoutis TE; Benjamin DK; Steinbach WJ
    Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer antifungal therapy for emerging fungal pathogens.
    Steinbach WJ; Perfect JR
    Int J Infect Dis; 2003 Mar; 7(1):5-20. PubMed ID: 12718805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B].
    Viscoli C; Castagnola E
    Recenti Prog Med; 1999 Oct; 90(10):545-57. PubMed ID: 10592741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients.
    Almyroudis NG; Segal BH
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1451-66. PubMed ID: 21133669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
    Kratzer C; Tobudic S; Schmoll M; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 2006 Nov; 58(5):1058-61. PubMed ID: 16987867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive mycoses: diagnostic challenges.
    Ostrosky-Zeichner L
    Am J Med; 2012 Jan; 125(1 Suppl):S14-24. PubMed ID: 22196205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].
    Salavert M; Jarque I
    Rev Esp Quimioter; 2006 Mar; 19(1):11-3. PubMed ID: 16688286
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection and investigation of invasive mould disease.
    Cuenca-Estrella M; Bassetti M; Lass-Flörl C; Rácil Z; Richardson M; Rogers TR
    J Antimicrob Chemother; 2011 Jan; 66 Suppl 1():i15-24. PubMed ID: 21177400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.